z-logo
open-access-imgOpen Access
Trials of arsenic trioxide therapy should be envisioned for severely respiratory distress syndrome related to a cytokine storm in COVID-19 patients
Author(s) -
François Rieger
Publication year - 2020
Publication title -
japan journal of research
Language(s) - English
Resource type - Journals
ISSN - 2690-8077
DOI - 10.33425/2690-8077.1023
Subject(s) - cytokine storm , arsenic trioxide , covid-19 , medicine , intensive care medicine , acute respiratory distress , respiratory distress , arsenic , anesthesia , virology , outbreak , lung , chemistry , disease , organic chemistry , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom